ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,583Medicare Part D Prescriptions Filled, Including Refills

Rank: 285 out of 1111

$382K Total Retail Price of All Prescriptions

Rank: 357 out of 1111

304 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 304 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 304 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

3% of this provider’s 5,050 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
METFORMIN HCL 255 164 1 8
HYDROCODONE-ACETAMINOPHEN 236 125 S3 2 1
TRAMADOL HCL 190 118 3 13
LEVOTHYROXINE SODIUM 190 135 3 3
CARVEDILOL 180 138 5 21
BENAZEPRIL HCL 171 144 6 97
LISINOPRIL 169 132 7 2
OXYCODONE HCL 152 46 S2 8 69
FUROSEMIDE 151 131 9 6
AMLODIPINE BESYLATE 137 122 10 7
SPIRONOLACTONE 129 95 11 83
CITALOPRAM HBR 129 84 11 14
OMEPRAZOLE 129 79 11 4
DIGOXIN 121 88 14 47
LOVASTATIN 116 58 15 41
POTASSIUM CHLORIDE 114 99 16 9
METHADONE HCL 107 0 S2 17 188
BISOPROLOL-HYDROCHLOROTHIAZIDE 101 50 18 143
BUPROPION HCL 101 67 18 275
ATENOLOL 99 65 20 22
GABAPENTIN 97 50 21 10
FLUTICASONE PROPIONATE 95 71 22 27
ENALAPRIL MALEATE 93 85 23 56
METOPROLOL TARTRATE 90 75 24 12
FENTANYL 89 66 S2 25 65
TIZANIDINE HCL 85 30 26 91
AMITRIPTYLINE HCL 85 55 R 26 64
LYRICA 81 56 28 62
LOSARTAN POTASSIUM 74 70 29 34
THEOPHYLLINE ANHYDROUS 72 53 30 344
WARFARIN SODIUM 70 45 31 19
LANTUS 70 60 31 46
ALLOPURINOL 69 49 33 36
ZOLPIDEM TARTRATE 68 63 34 16
GLIPIZIDE 68 60 34 57
SIMVASTATIN 68 42 34 5
FAMOTIDINE 65 52 37 77
DOXYCYCLINE HYCLATE 63 50 38 113
SERTRALINE HCL 60 34 39 24
VOLTAREN 54 29 40 236
CEPHALEXIN 51 36 41 89
CARBIDOPA-LEVODOPA 50 47 42 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 30, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.